Regional Latent TB Infection (LTBI) Echo Series

Date: August 31- December 14, 2021
Location: Online

COURSE DESCRIPTION & OVERALL GOAL
The purpose of this training is to increase primary care providers’ knowledge and influence practice change for testing and treatment of TB infection. Topics to be covered will include risk-based screening, available diagnostic tests and interpretation, treatment options, approaches for monitoring and managing patients during treatment, and pediatric considerations for testing and treating LTBI in children. This education series will include a total of 7 webinars and each session will feature a 15- minute didactic session followed by participant-led case presentations and discussion among the network of primary care providers. The series is in collaboration with Brown University.

WHO SHOULD ATTEND
This webinar series is open to primary care providers and nurse practitioners who are involved in the care of high risk populations to test and treat latent TB infection in primary care.

OBJECTIVES
Upon completion of this conference, participants should be better able to:

• Explain the rationale for increased focus on identifying and treating TB infection to sustain progress toward TB elimination in the US.
• Identify priority populations who should be screened for TB infection based on risk.
• Select appropriate tests for LTBI screening and interpret results within the context of the individual patient.
• Implement shorter regimens to increase treatment completion among patients with TB infection.
• Outline the diagnosis and treatment of LTBI in children to prevent increased morbidity and mortality.

COURSE REQUIREMENTS
In order to meet the learning objectives and receive continuing education credits, participants are required to attend live webinar sessions and complete an evaluation form.

AGENDA
The dates for the live sessions are as shown below.

CONNECTION INFORMATION
These weekly webinar sessions will be hosted via Zoom. Registration is limited to primary care providers who interface with persons at high risk for TB. If you are a primary care provider and would like to register, please contact Shwata Suresh Kumar at ss2980@rutgers.edu.

For more information, please click on the link below:
https://sites.brown.edu/project-echo/

CONTINUING EDUCATION INFORMATION
In support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE POLICY
All individuals who affect content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made to the audience at the time of the activity.

REGISTRATION INFORMATION & FEE
This education series is open only to primary care providers and registration is by invitation only.

There is no fee for the webinar series.

FUNDING DISCLOSURE
Funding for this conference was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

For any additional questions, please contact Shwata Suresh Kumar at ss2980@rutgers.edu.